Cas:14534-87-3 iron(3+),tribenzoate manufacturer & supplier

We serve Chemical Name:iron(3+),tribenzoate CAS:14534-87-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

iron(3+),tribenzoate

Chemical Name:iron(3+),tribenzoate
CAS.NO:14534-87-3
Synonyms:Iron tribenzoate;ferrous benzoate;FERRIC BENZOATE;iron benzoate;ferric iron tribenzoate
Molecular Formula:C21H15FeO6
Molecular Weight:419.18500
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:249.3ºC at 760mmHg
Density:N/A
Index of Refraction:
PSA:78.90000
Exact Mass:419.02200
LogP:3.92060

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Iron tribenzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ferric iron tribenzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Iron tribenzoate Use and application,Iron tribenzoate technical grade,usp/ep/jp grade.


Related News: While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. iron(3+),tribenzoate manufacturer GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.�� iron(3+),tribenzoate supplier GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.�� iron(3+),tribenzoate vendor While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. iron(3+),tribenzoate factory GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.��